Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:325763rdf:typepubmed:Citationlld:pubmed
pubmed-article:325763lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:325763lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:325763lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:325763lifeskim:mentionsumls-concept:C0010583lld:lifeskim
pubmed-article:325763pubmed:issue1lld:pubmed
pubmed-article:325763pubmed:dateCreated1977-7-18lld:pubmed
pubmed-article:325763pubmed:abstractTextCanine cyclophosphamide (CY) chimeras permanently accept kidney and skin grafts as do radiation chimeras. Three of five dogs with reversion of chimerism rejected their kidney grafts within 11-16 days, while two of them retained their kidney grafts permanently. These results suggest that the reversion of chimerism in CY chimeras may be due to different mechanisms, either immunologic rejection or a nonimmunologic substitution of the grafted marrow by the host's own hemopoiesis.lld:pubmed
pubmed-article:325763pubmed:languageenglld:pubmed
pubmed-article:325763pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:325763pubmed:citationSubsetIMlld:pubmed
pubmed-article:325763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:325763pubmed:statusMEDLINElld:pubmed
pubmed-article:325763pubmed:monthMarlld:pubmed
pubmed-article:325763pubmed:issn0041-1345lld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:KolbH JHJlld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:RiederIIlld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:PielstickerKKlld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:Grosse-WildeH...lld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:ScholzSSlld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:DuswaldK HKHlld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:ChaussyCClld:pubmed
pubmed-article:325763pubmed:authorpubmed-author:von ScheelJJlld:pubmed
pubmed-article:325763pubmed:issnTypePrintlld:pubmed
pubmed-article:325763pubmed:volume9lld:pubmed
pubmed-article:325763pubmed:ownerNLMlld:pubmed
pubmed-article:325763pubmed:authorsCompleteYlld:pubmed
pubmed-article:325763pubmed:pagination261-3lld:pubmed
pubmed-article:325763pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-A...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-K...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-D...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-B...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-T...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-G...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-C...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-B...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-K...lld:pubmed
pubmed-article:325763pubmed:meshHeadingpubmed-meshheading:325763-R...lld:pubmed
pubmed-article:325763pubmed:year1977lld:pubmed
pubmed-article:325763pubmed:articleTitleKidney transplantation following treatment with cyclophosphamide and bone marrow grafting.lld:pubmed
pubmed-article:325763pubmed:publicationTypeJournal Articlelld:pubmed